What is Amgen's total equity?

Amgen (AMGN) reported total equity of $9.19B in Q1 2026.

How has Amgen's total equity changed year-over-year?

Amgen's total equity increased by 48.1% year-over-year, from $6.21B to $9.19B.

What is the long-term trend for Amgen's total equity?

Over 5 years (2020 to 2025), Amgen's total equity has grown at a -1.6% compound annual growth rate (CAGR), from $9.41B to $8.66B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Amgen AMGN Total Equity

Total Equity at other companies

Eli LillyLLY

$31.2B+97.9%

PfizerPFE

$90.1B-0.3%

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

Nektar TherapeuticsNKTR

$576.22M+4,094%

Oruka Therapeutics, Inc.ORKA

$486.72M+33.4%

Rigel PharmaceuticalsRIGL

$399.9M+2,054%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$197.56B+20.9%

Enterprise value$254.32B+16.1%

P/E25.3×+0.6×

P/S5.3×+0.6×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's total equity?: Amgen (AMGN) reported total equity of $9.19B in Q1 2026.
How has Amgen's total equity changed year-over-year?: Amgen's total equity increased by 48.1% year-over-year, from $6.21B to $9.19B.
What is the long-term trend for Amgen's total equity?: Over 5 years (2020 to 2025), Amgen's total equity has grown at a -1.6% compound annual growth rate (CAGR), from $9.41B to $8.66B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.